Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.500
+0.110 (3.24%)
At close: Jan 21, 2026, 4:00 PM EST
3.490
-0.010 (-0.29%)
Pre-market: Jan 22, 2026, 4:12 AM EST
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.23 billion as of January 22, 2026. Its market cap has decreased by -21.38% in one year.
Market Cap
1.23B
Enterprise Value
1.52B
1-Year Change
-21.38%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.23B, an increase of 235.52%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.23B | 8.11% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ANI Pharmaceuticals | 1.79B |
| Dynavax Technologies | 1.78B |
| Harrow | 1.77B |
| Phibro Animal Health | 1.67B |
| Alvotech | 1.55B |
| Collegium Pharmaceutical | 1.51B |
| BioCryst Pharmaceuticals | 1.40B |
| Amphastar Pharmaceuticals | 1.19B |